THE ROLE OF POLYMORPHISMS OF CRP GENE IN OCCURRENCE OF ATRIAL FIBRILATION IN CAD PATIENTS
https://doi.org/10.17802/2306-1278-2017-6-3-37-46
Abstract
The purpose. Assessment of the contribution of CRP gene polymorphisms rs3093077, rs1130864 and rs1205 to the development of atrial fibrillation (AF) in CAD patients depending on gender and age.
Material and methods. The study included 302 patients with stable coronary artery disease. C-reactive protein (CRP) concentration was measured by high-sensitive immunoturbidimetric assay. The genotyping was performed in 96-well plates using TaqMan assay.
Results. The elderly age > 65 years and the presence of type 2 diabetes mellitus are the clinical and anamnestic predictors of AF development (р=0.003; 0.01). G/A rs1130864 CRP heterozygous carriers have a 4-fold increased risk of AF development among the patients with coronary artery disease (p=0.0025) according to the overdominant inheritance model. Men who are the carriers of С/Т rs1205 CRP genotype have on average a 5-fold increased risk of AF development in case of CAD presence (according to the overdominant model, р=0.022). A 5-fold increased risk of AF development is associated with men carrying G/A rs1130864 CRP genotype (p=0.015), meanwhile the men < 65 years, who carry the same genotype (rs1130864 CRP), have a 9-fold increased risk of AF development (p=0.025), as compared to the patients who are the carriers of other genotypes.The patients of both genders < 65 years, carrying the С/Т rs1205 CRP genotype, have a 10-fold increased risk of AF development as compared to the carriers of other genotypes (OR =10.03 (1.26-79.59); 95% CI).
Conclusion. The genetic markers should be considered to assess the risk of AF development.
About the Authors
Yu. V. Bayrakova
Federal State Budgetary Institution Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
6, Sosnoviy blvd., Kemerovo, 650002
Russian Federation
6, Sosnoviy blvd., Kemerovo, 650002
P. A. Ponasenko
Federal State Budgetary Institution Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Kemerovo
Russian Federation
Kemerovo
M. V. Khutornaya
Federal State Budgetary Institution Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Kemerovo
Russian Federation
Kemerovo
A. A. Kuzmina
Federal State Budgetary Institution Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Kemerovo
Russian Federation
Kemerovo
Ya. V. Kazachek
Federal State Budgetary Institution Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Kemerovo
Russian Federation
Kemerovo
O. L. Barbarash
Federal State Budgetary Institution Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Kemerovo
Russian Federation
Kemerovo
References
1. Симоненко В.Б., Борисов И.А., Голиков А.П., Диева Т.В., Савичев Д.Д. Фибрилляция предсердий после аортокоронарного шунтирования. Клиническая медицина. 2009; 8; 4-6. Simonenko V.B., Borisov I.A., Golikov A.P., Dieva T.V., Savichev D.D. Atrial fibrillation after coronary artery bypass grafting. Klinicheskaya meditsina. 2009; 8; 4-6. [In Russ]
2. De Jong M.J., Morton P.G. Predictors of atrial dysrhythmias for patients undergoing coronary artery bypass grafting. Am. J. Crit. Care. 2000; 9(6): 388-396.
3. Abusaada K., Sharma S.B., Jaladi R., Ezekowitz M.D. Epidemiology and management of new-onset atrial fibrillation. Am. J. Manag. Care. 2004; 10(3 Suppl.): 50-57.
4. Libby P., Ridker M.P., Hansson K.G. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 2009; 54(23): 2129-2138. doi: 10.1016/j.jacc.2009.09.009.
5. Жукова В.А., Шальнова С.А., Метельская В.А. С-реактивный белок: современное состояние проблемы. Кардиоваскулярная терапия и профилактика. 2011; 10 (1): 90-95. Zhukova V.A., Shalnova S.A., Metelskaya V.A. C-reactive protein: modern state of the problem. Kardiovaskulyarnaya terapiya i profilaktika. 2011; 10 (1): 90-95. [In Russ]
6. Arribas-Leal J.M., Pascual-Figal D.A., TornelOsorio P.L., Gutiérrez-García F., García-Puente del Corral J.J., Ray-López V.G. et al. Epidemiology and new predictors of atrial fibrillation after coronary surgery. Rev. Esp. Cardiol. 2007; 60(8): 841-847. doi: 10.1016/S1885-5857(08)60028-6.
7. Митьковская Н.П., Герасименок Д.С., Ходосовская Е.В., Картун Л.В. Активность воспалительного ответа у пациентов с сочетанием острого коронарного синдрома и острого ишемического повреждения мозга. Медицинский журнал. 2008; 3: 100-102. Mit’kovskaya N.P., Gerasimenok D.S., Khodosovskaya E.V., Kartun L.V. Aktivnost’ vospalitel’nogo otveta u patsientov s sochetaniem ostrogo koronarnogo sindroma i ostrogo ishemicheskogo povrezhdeniya mozga. Meditsinskiy zhurnal. 2008; 3: 100-102. [In Russ]
8. Almagor M., Keren A., Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am. Heart J. 2003; 145(2): 248-253. doi: 10.1067/mhj.2003.16.
9. Игитова М.Б., Воробьева Е.В., Осипова И.В., Гольцова Н.П. Роль системного воспаления в развитии кардиоваскулярной и акушерской патологии. Кардиоваскулярная терапия и профилактика. 2009; 1: 81-87. Igitova M.B., Vorobieva E.V., Osipova I.V., Gol’tsova N.P. System inflammation role in cardiovascular and obstetric pathology. Kardiovaskulyarnaya terapiya i profilaktika. 2009; 1: 81-87. [In Russ]
10. Ellinor P.T., Low A., Patton K.K., Shea M.A., MacRae C.A. C-reactive protein in lone atrial fibrillation. Am. J. Cardiol. 2006; 97(9): 1346-1350. doi: 10.1016/j.amjcard.2005.11.052.
11. Pirat B., Atar I., Ertan C., Bozbas H., Gulmez O., Müderrisoglu H. et al. Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study. Am. J. Cardiol. 2007; 100(10): 1552-1555. doi: 10.1016/j.amjcard.2007.06.056.
12. Байракова Ю.В, Иванов С.В., Казачек Я.В., Баздырев Е.Д., Малышенко Е.С., Кургузова Е.М. и др. Факторы риска развития суправентрикулярных нарушений ритма в госпитальном периоде после коронарного шунтирования. Сибирский медицинский журнал. 2011; 104(5): 44-47. Bayrakova Y.V., Ivanov S.V., Kazachek Y.V., Bazdyrev E.D., Malyshenko E.S., Кurguzova E.M. et al. Risk factors for inhospital supraventricular rhythm disturbances after coronary bypass surgery. Sibirskiy meditsinskiy zhurnal. 2011; 104(5): 44-47. [In Russ]
13. Байракова Ю.В., Григорьев А.М., Баздырев Е.Д., Казачек Я.В., Барбараш О.Л., Барбараш Л.С. Роль субклинического воспаления в развитии сердечно-сосудистых осложнений у пациентов после коронарного шунтирования. Кардиология и сердечно-сосудистая хирургия. 2013; 6(3): 18-22. Baĭrakova Iu.V., Grigor’ev A.M., Bazdyrev E.D., Kazachek Ia.V., Barbarash O.L., Barbarash L.S. Role of subclinical inflammation in development of cardiovascular complications in patients after coronary bypass grafting. Kardiologiya i serdechnososudistaya khirurgiya. 2013; 6(3): 18-22. [In Russ]
14. Байракова Ю.В., Баздырев Е.Д., Казачек Я.В., Головкин А.С., Матвеева В.Г., Кузьмина А.А. и др. Периоперационная динамика маркеров воспаления у пациентов с ишемической болезнью сердца, подвергшихся коронарному шунтированию. Цитокины и воспаление. 2012; 11(1): 55-59.
15. Bayrakova Yu.V., Bazdyrev E.D., Cazachek Ya.V., Golovkin A.S., Matveeva V.G., Kuzmina A.A. Perioperative dynamics of inflammatory markers in patients with coronary heart disease underwent coronary artery bypass grafting. Tsitokiny i vospalenie. 2012; 11(1): 55-59. [In Russ]
16. Байракова Ю.В., Казачек Я.В., Груздева О.В., Сергеева Т.Ю., Григорьев А.М., Иванов С.В. Периоперационная динамика С-реактивного белка у пациентов, подвергшихся коронарному шунтированию. Клиническая и лабораторная диагностика. 2013; 3: 3-6. Bayrakova Yu.V., Kazatchek Ya.V., Gruzdeva O.V., Sergeyeva T. Yu., Grigoriyev A.M., Ivanov S.V. The dynamics of C-reactive protein in the process of coronary artery bypass grafting in patients with ischemic heart disease. Klinicheskaya i laboratornaya diagnostika. 2013; 3: 3-6. [In Russ]
17. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A. et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003; 108(24): 3006-3010. doi: 10.1161/01.CIR.0000103131.70301.4F.
18. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A. et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001; 104(24): 2886-2891. doi: http://dx.doi.org/10.1161/hc4901.101760.
19. Anderson J.L., Allen Maycock C.A., Lappe D.L., Crandall B.G., Horne BD, Bair T.L. et al. Frequency of elevation of C-reactive protein in atrial fibrillation. Am. J. Cardiol. 2004; 94(10): 1255-1259. doi: 10.1016/j.amjcard.2004.07.108.
20. Барбараш О.Л, Байракова Ю.В., Понасенко А.В., Хуторная М.В., Кузьмина А.А., Казачек Я.В. и др. Связь полиморфизмов гена С-реактивного белка с развитием инфаркта миокарда и формированием мультифокального атеросклероза у пациентов с ИБС. Атеросклероз. 2015; 11(4): 11-19. Barbarash O.L., Bayrakova Yu.V., Ponasenko A.V., Khutornaya M.V., Kuz’mina A.A., Kazachek Ya.V. The relationship of gene polymorphisms of C-reactive protein with the development of myocardial infarction and formation of multifocal atherosclerosis in CHD patients. Ateroskleroz. 2015; 11(4): 11-19. [In Russ]
21. Marott S.C., Nordestgaard B.G., Zacho J., Friberg J., Jensen G.B., Tybjaerg-Hansen A. et al. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population. J. Am. Coll. Cardiol. 2010; 56(10): 789-795. doi: 10.1016/j.jacc.2010.02.066.
Review
For citations:
Bayrakova Yu.V., Ponasenko P.A., Khutornaya M.V., Kuzmina A.A., Kazachek Ya.V., Barbarash O.L. THE ROLE OF POLYMORPHISMS OF CRP GENE IN OCCURRENCE OF ATRIAL FIBRILATION IN CAD PATIENTS. Complex Issues of Cardiovascular Diseases. 2017;(3):37-46. (In Russ.) https://doi.org/10.17802/2306-1278-2017-6-3-37-46
Views:
702
